Abstract
To the Editor: Acitretin is highly teratogenic when given to women before and during pregnancy, but data concerning paternal acitretin exposure and adverse pregnancy outcomes are limited.1,2 To support this, we conducted a nationwide register-based cohort study including all registered pregnancies in Denmark between 1997 and 2016. Information on registered pregnancies was obtained from the Medical Birth Registry and National Hospital Registry.3,4 Paternal acitretin exposure was identified from the National Prescription Registry holding information on all redeemed prescriptions in the country.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
